Detalhe da pesquisa
1.
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort.
J Urol
; 209(5): 882-889, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795962
2.
Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer.
J Urol
; 207(1): 70-76, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34445891
3.
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
World J Urol
; 40(11): 2707-2715, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169695
4.
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
BJU Int
; 127(5): 528-537, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32981193
5.
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis.
BJU Int
; 128(1): 79-87, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152179
6.
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.
World J Urol
; 39(12): 4345-4354, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34370078
7.
Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer.
J Urol
; 204(4): 748-753, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32259468
8.
Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers.
Cancer
; 125(3): 391-397, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30423193
9.
Clinical Validation of IsoPSA™, a Single Parameter, Structure Based Assay for Improved Detection of High Grade Prostate Cancer.
J Urol
; 201(6): 1115-1120, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30810464
10.
Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer.
Invest New Drugs
; 37(6): 1231-1238, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31231785
11.
Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancer.
Invest New Drugs
; 37(3): 559-566, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31037562
12.
Does time from diagnosis to treatment of high- or very-high-risk prostate cancer affect outcome?
BJU Int
; 124(2): 282-289, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30653804
13.
Genomic Scores are Independent of Disease Volume in Men with Favorable Risk Prostate Cancer: Implications for Choosing Men for Active Surveillance.
J Urol
; 199(2): 438-444, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28941920
14.
Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable Features.
J Urol
; 199(2): 445-452, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28789947
15.
Effects of pathological upstaging or upgrading on metastasis and cancer-specific mortality in men with clinical low-risk prostate cancer.
BJU Int
; 122(6): 1003-1009, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29802773
16.
Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours.
Curr Opin Urol
; 28(5): 448-453, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29979237
17.
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
JAMA
; 319(9): 896-905, 2018 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29509865
18.
Pro: Magnetic Resonance Imaging Targeting Leads to Overtreatment of Prostate Cancer.
J Urol
; 208(2): 246-247, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549453
19.
Outcomes of Active Surveillance after Initial Surveillance Prostate Biopsy.
J Urol
; 197(1): 84-89, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27449260
20.
Do Renin-Angiotensin Blockers Affect Renal Function and Cardiac Outcomes in Patients Undergoing Partial Nephrectomy?
J Urol
; 197(3 Pt 1): 566-573, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27746281